For instance, humanized monoclonal antibodies that are specific for inhibitory receptors (such as CTLA-4, PD-1, LAG-3, and TIM-3) and ligands (PD-L1) expressed on T lymphocytes, antigen-presenting cells, and tumor cells. The gene discussed is CTLA4; the disease is neoplasm.